Atara Biotherapeutics Inc ATRA

NAS: ATRA | ISIN: US0465131078   6/05/2026
5,150 USD (+8,19%)
(+8,19%)   6/05/2026
Grafiek Atara Biotherapeutics Inc Grafiek Atara Biotherapeutics Inc

Atara Biotherapeutics Inc in het nieuws

1 mei 2026 · ATRA SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026 · Persbericht

1 mei 2026 · Pomerantz Law Firm Announces the Filing of a Class Action Against Atara Biotherapeutics, Inc. and Certain Officers - ATRA · Persbericht

29 april 2026 · Lost Money on Atara Biotherapeutics, Inc.(ATRA)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky · Persbericht

24 april 2026 · Atara Biotherapeutics, Inc. (ATRA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit · Persbericht

22 april 2026 · Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 22, 2026 in Atara Biotherapeutics, Inc. Lawsuit - ATRA · Persbericht

17 april 2026 · Atara Biotherapeutics, Inc. (ATRA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit · Persbericht

17 april 2026 · ATRA Stockholders Have Rights - If You Lost Money Investing in Atara Biotherapeutics, Inc. Contact Robbins LLP for Information About Recovering Your Losses · Persbericht

16 april 2026 · Pomerantz Law Firm Announces the Filing of a Class Action Against Atara Biotherapeutics, Inc. and Certain Officers - ATRA · Persbericht

16 april 2026 · ATRA INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026 · Persbericht

10 april 2026 · Atara Biotherapeutics, Inc. (ATRA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit · Persbericht

Profiel Atara Biotherapeutics Inc

Biotechnologie
Gezondheidstechnologie
Productie
Productie van biologische producten

Website: www.atarabio.com

Hoofdzetel: South San Francisco, California vlag Verenigde Staten

Mijn selecties